Skip to main content
Log in

Clinical Evaluation of the Efficacy and Safety of Topically Applied Imidacloprid plus Moxidectin against Ear Mites (Otodectes cynotis) in Client-Owned Cats

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript


A multi-centred clinical field study was conducted to evaluate the safety and efficacy of a 10% imidacloprid / 1% moxidectin combination against ear mites (Otodectes cynotis) in client-owned cats. Veterinarians and staff from six veterinary clinics (USA) participated in the study.

Single- and multi-cat households were enrolled in the study. In multi-cat households, all cats were evaluated for safety, but only one cat in the household was randomly chosen for evaluation of efficacy. Ninety-three (93) households with 332 cats were evaluated for safety, and 77 households with 301 cats were evaluated for efficacy. Each household was randomly assigned to a treatment group: imidacloprid/moxidectin or selamectin.

Treatments were administered twice, approximately 30 days apart, by the cat’s owner. Otoscopic examinations were performed on the cats by the investigators for the presence of ear mites prior to treatment, and approximately 30 days after each treatment.

Imidacloprid/moxidectin provided 92.5 and 98.1% ear mite efficacy following the first and second treatments, while selamectin provided 91.7 and 95.8% efficacy following the two respective treatments. No serious adverse events related to treatment with either product were observed during the study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  • Arther RG, Charles S, Ciszewski DK, Davis WL, Settje TS (2005). Imidacloprid/moxidectin topical solution for the prevention of heartworm disease and the treatment and control of flea and intestinal nematodes of cats. Veterinary Parasitology 133:219–225.

    Google Scholar 

  • Krieger K, Heine J, Dumont P, Hellmann K (2005). Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spoton in the treatment of sarcoptic mange and otoacariosis in dogs: results of a European field study. Parasitology Research 97:S81–S88.

    Google Scholar 

  • Shanks DJ, McTier TL, Rowan TG, Watson P, Thomas CA, Bowman DD, Hair JA, Pengo G, Genchi C, Smothers CD, Smith DG, Jernigan AD (2000). The efficacy of selamectin in the treatment of naturally acquired aural infestations of Otodectes cynotis in dogs and cats. Vet Parasitol 91:283–290.

  • Six RH, Clemence RG, Thomas CA, Behan S, Boy MG, Watson P, Benchaoui HA, Clements PJM, Rowan TG, Jernigan AD (2000). Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients. Vet Parasitol 91:291–309.

  • Thomas CA (1999) Revolution™: A unique endectocide providing comprehensive, convenient protection. A Supplement to Compendium on Continuing Education for the Practicing Veterinarian, Vol. 21, No. 9(I):2–25.

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to W. L. Davis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, W., Arther, R. & Settje, T. Clinical Evaluation of the Efficacy and Safety of Topically Applied Imidacloprid plus Moxidectin against Ear Mites (Otodectes cynotis) in Client-Owned Cats. Parasitol Res 101 (Suppl 1), 19–24 (2007).

Download citation

  • Published:

  • Issue Date:

  • DOI: